117 related articles for article (PubMed ID: 38825157)
1. Type 3 resistant starch from Canna edulis reduce lipid levels in patients with mild hyperlipidemia through altering gut microbiome: A double- blind randomized controlled trial.
Miao T; Zhang X; Zhang C; Wu J; Zhu Y; Xiao M; Zhang N; Zhong Y; Liu Y; Lin Y; Wu Y; Li W; Song C; Liu Y; Wang X
Pharmacol Res; 2024 Jul; 205():107232. PubMed ID: 38825157
[TBL] [Abstract][Full Text] [Related]
2. A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin.
Zhang C; Ma S; Wu J; Luo L; Qiao S; Li R; Xu W; Wang N; Zhao B; Wang X; Zhang Y; Wang X
Pharmacol Res; 2020 Sep; 159():104985. PubMed ID: 32504839
[TBL] [Abstract][Full Text] [Related]
3. Type 3 resistant starch from
Wu J; Qiu M; Zhang C; Zhang C; Wang N; Zhao F; Lv L; Li J; Lyu-Bu AGA; Wang T; Zhao B; You S; Wu Y; Wang X
Food Funct; 2021 Nov; 12(23):12098-12114. PubMed ID: 34784410
[TBL] [Abstract][Full Text] [Related]
4. Preparation, structure characterization, and specific gut microbiota properties related to anti-hyperlipidemic action of type 3 resistant starch from Canna edulis.
Zhang C; Qiu M; Wang T; Luo L; Xu W; Wu J; Zhao F; Liu K; Zhang Y; Wang X
Food Chem; 2021 Jul; 351():129340. PubMed ID: 33662904
[TBL] [Abstract][Full Text] [Related]
5. Structure properties of Canna edulis RS3 (double enzyme hydrolysis) and RS4 (OS-starch and cross-linked starch): Influence on fermentation products and human gut microbiota.
Wang N; Zhang C; Li H; Wu J; Zhang D; Li Y; Yang L; Zhang N; Wang X
Int J Biol Macromol; 2024 Apr; 265(Pt 1):130700. PubMed ID: 38458281
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Effects of Cucumis sativus Seed Extract on Serum Lipids in Adult Hyperlipidemic Patients: A Randomized Double-Blind Placebo-Controlled Clinical Trial.
Soltani R; Hashemi M; Farazmand A; Asghari G; Heshmat-Ghahdarijani K; Kharazmkia A; Ghanadian SM
J Food Sci; 2017 Jan; 82(1):214-218. PubMed ID: 27886382
[TBL] [Abstract][Full Text] [Related]
7. Aqueous extract of fermented Eucommia ulmoides leaves alleviates hyperlipidemia by maintaining gut homeostasis and modulating metabolism in high-fat diet fed rats.
Duan Y; Guo F; Li C; Xiang D; Gong M; Yi H; Chen L; Yan L; Zhang D; Dai L; Liu X; Wang Z
Phytomedicine; 2024 Jun; 128():155291. PubMed ID: 38518640
[TBL] [Abstract][Full Text] [Related]
8. Combined berberine and probiotic treatment as an effective regimen for improving postprandial hyperlipidemia in type 2 diabetes patients: a double blinded placebo controlled randomized study.
Wang S; Ren H; Zhong H; Zhao X; Li C; Ma J; Gu X; Xue Y; Huang S; Yang J; Chen L; Chen G; Qu S; Liang J; Qin L; Huang Q; Peng Y; Li Q; Wang X; Zou Y; Shi Z; Li X; Li T; Yang H; Lai S; Xu G; Li J; Zhang Y; Gu Y; Wang W
Gut Microbes; 2022; 14(1):2003176. PubMed ID: 34923903
[TBL] [Abstract][Full Text] [Related]
9. Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial.
Tong X; Xu J; Lian F; Yu X; Zhao Y; Xu L; Zhang M; Zhao X; Shen J; Wu S; Pang X; Tian J; Zhang C; Zhou Q; Wang L; Pang B; Chen F; Peng Z; Wang J; Zhen Z; Fang C; Li M; Chen L; Zhao L
mBio; 2018 May; 9(3):. PubMed ID: 29789365
[TBL] [Abstract][Full Text] [Related]
10. Study of the self-assembly, drug encapsulating and delivering characteristics of short chain amylose-based type 3 resistant starch nanoparticles from Canna edulis.
Zhang C; Tang L; Wang N; Wu J; Zhang D; Li H; Li Y; Yang L; Zhang N; Zhang Y; Wang X
Int J Biol Macromol; 2024 Mar; 262(Pt 2):130107. PubMed ID: 38350585
[TBL] [Abstract][Full Text] [Related]
11. A randomized trial to determine the impact of a digestion resistant starch composition on the gut microbiome in older and mid-age adults.
Alfa MJ; Strang D; Tappia PS; Graham M; Van Domselaar G; Forbes JD; Laminman V; Olson N; DeGagne P; Bray D; Murray BL; Dufault B; Lix LM
Clin Nutr; 2018 Jun; 37(3):797-807. PubMed ID: 28410921
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of Hwangryunhaedok-tang (Huang-lian-jie-du-tang, Oren-gedoku-to) for patients with hyperlipidemia: a study protocol for a randomized, double-blind, placebo-controlled, parallel, investigator-initiated clinical trial.
Lee B; Han K; Park HJ; Kim AR; Kwon OJ; Yang C; Cho CS
Trials; 2020 Aug; 21(1):750. PubMed ID: 32854756
[TBL] [Abstract][Full Text] [Related]
13. Rhus coriaria L. increases serum apolipoprotein-A1 and high-density lipoprotein cholesterol levels: a double-blind placebo-controlled randomized clinical trial.
Hajmohammadi Z; Heydari M; Nimrouzi M; Faridi P; Zibaeenezhad MJ; Omrani GR; Shams M
J Integr Med; 2018 Jan; 16(1):45-50. PubMed ID: 29397092
[TBL] [Abstract][Full Text] [Related]
14. Mangiferin supplementation improves serum lipid profiles in overweight patients with hyperlipidemia: a double-blind randomized controlled trial.
Na L; Zhang Q; Jiang S; Du S; Zhang W; Li Y; Sun C; Niu Y
Sci Rep; 2015 May; 5():10344. PubMed ID: 25989216
[TBL] [Abstract][Full Text] [Related]
15. Does a high dietary intake of resistant starch affect glycaemic control and alter the gut microbiome in women with gestational diabetes? A randomised control trial protocol.
Latino C; Gianatti EJ; Mehta S; Lo J; Devine A; Christophersen C
BMC Pregnancy Childbirth; 2022 Jan; 22(1):46. PubMed ID: 35042457
[TBL] [Abstract][Full Text] [Related]
16. Advancements in enhancing resistant starch type 3 (RS3) content in starchy food and its impact on gut microbiota: A review.
Feng H; Cheng B; Lim J; Li B; Li C; Zhang X
Compr Rev Food Sci Food Saf; 2024 May; 23(3):e13355. PubMed ID: 38685870
[TBL] [Abstract][Full Text] [Related]
17. Wheat Gluten Regulates Cholesterol Metabolism by Modulating Gut Microbiota in Hamsters with Hyperlipidemia.
Liang TT; Tong LT; Geng DH; Wang LL; Zhou XR; Pu HY; Jia W; Wu QP; Huang JR
J Oleo Sci; 2019; 68(9):909-922. PubMed ID: 31484903
[TBL] [Abstract][Full Text] [Related]
18. A randomized, double-blind clinical study of the effects of Ankascin 568 plus on blood lipid regulation.
Liu SF; Wang YR; Shen YC; Chen CL; Huang CN; Pan TM; Wang CK
J Food Drug Anal; 2018 Jan; 26(1):393-400. PubMed ID: 29389579
[TBL] [Abstract][Full Text] [Related]
19. Synergistic Effects of Lotus Seed Resistant Starch and Sodium Lactate on Hypolipidemic Function and Serum Nontargeted Metabolites in Hyperlipidemic Rats.
Liu L; Lin Y; Lei S; Zhang Y; Zeng H
J Agric Food Chem; 2021 Dec; 69(48):14580-14592. PubMed ID: 34735157
[TBL] [Abstract][Full Text] [Related]
20. Neither raw nor retrograded resistant starch lowers fasting serum cholesterol concentrations in healthy normolipidemic subjects.
Heijnen ML; van Amelsvoort JM; Deurenberg P; Beynen AC
Am J Clin Nutr; 1996 Sep; 64(3):312-8. PubMed ID: 8780339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
